DiscoverNovel and Emerging Approaches to Melanoma Management: Perspectives for the Community ClinicianUnderstanding and Overcoming Resistance to Anti-PD-1 Immunotherapy in Melanoma
Understanding and Overcoming Resistance to Anti-PD-1 Immunotherapy in Melanoma

Understanding and Overcoming Resistance to Anti-PD-1 Immunotherapy in Melanoma

Update: 2022-08-31
Share

Description

Michael Davies hosts a series of 4 podcasts with leading experts to discuss important topics in melanoma. 

Credit available for this activity expires: 08/31/23

Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/979092?src=mkm_podcast_series_979092

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Understanding and Overcoming Resistance to Anti-PD-1 Immunotherapy in Melanoma

Understanding and Overcoming Resistance to Anti-PD-1 Immunotherapy in Melanoma